Tumor necrosis factor alpha and interleukin-1 beta levels in cerebrospinal fluid examination for the diagnosis of ventriculoperitoneal shunt-related ventriculitis.


Journal

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227

Informations de publication

Date de publication:
04 2019
Historique:
received: 23 12 2018
accepted: 20 01 2019
pubmed: 29 1 2019
medline: 11 6 2020
entrez: 29 1 2019
Statut: ppublish

Résumé

Ventriculitis is known to develop after chronic inflammation and bacterial invasion of the ventricular surface with a recurrence of shunt infections. The aim of this study is to evaluate the diagnostic value of elevation in cerebrospinal fluid (CSF) interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α) together with CSF culture and laboratory test results in the diagnosis of ventriculoperitoneal (VP) shunt-related ventriculitis, which is known to be more problematic than conventional shunt infection. The study included a total of 34 patients with a VP shunt due to hydrocephalus, who presented with a headache, fever, and shunt infection at the Emergency Department and had a pre-diagnosis of ventriculitis. Nineteen patients were diagnosed with shunt-related infection or ventriculitis using the CSF obtained from the shunt pump. The IL-1β and TNF-α levels from the CSF samples of all patients were measured using the Micro ELISA immunoassay method. CSF direct microscopic observation revealed that the mean cell count, IL-1β level, CRP level, and blood leukocyte level were higher in patients with ventriculitis compared to those diagnosed with shunt infection (p = 0.02, p = 0.009, p = 0.004, and p = 0.009, respectively). The probability of predicting positive culture outcome was 92.7% with 90.9% sensitivity and 82.6% specificity when IL-1β values exceeded 4.0 pg/ml. TNF-α values did not show a significant, reliable pattern compared to IL-1β. IL-1β is a reliable parameter which shall be used in the diagnosis of ventriculitis by predicting positive culture outcome with high sensitivity and specificity.

Identifiants

pubmed: 30687902
doi: 10.1007/s00381-019-04070-x
pii: 10.1007/s00381-019-04070-x
doi:

Substances chimiques

Biomarkers 0
IL1B protein, human 0
Interleukin-1beta 0
TNF protein, human 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

629-636

Références

Childs Nerv Syst. 2001 Aug;17(8):453-6
pubmed: 11508533
J Crit Care. 2015 Feb;30(1):218.e1-5
pubmed: 25449880
Chemotherapy. 2005 Oct;51(6):363-5
pubmed: 16227692
Br J Neurosurg. 2000 Feb;14(1):7-12
pubmed: 10884877
Crit Care Med. 1997 Oct;25(10):1713-6
pubmed: 9377887
Acta Neurochir (Wien). 2011 Sep;153(9):1797-805
pubmed: 21769739
Asian J Endosc Surg. 2015 May;8(2):180-4
pubmed: 25913583
Crit Care Med. 2000 Jan;28(1):215-9
pubmed: 10667525
Acta Neurochir (Wien). 1996;138(7):829-34
pubmed: 8869711
Kurume Med J. 1992;39(4):257-65
pubmed: 1305908
J Neurol. 2008 Nov;255(11):1617-24
pubmed: 19156484
J Neurosurg. 2005 Sep;103(3 Suppl):223-30
pubmed: 16238075
J Biomed Mater Res A. 2014 May;102(5):1527-36
pubmed: 23765644
Pediatr Neurol. 2006 Jan;34(1):25-9
pubmed: 16376274
J Infect Dis. 1975 May;131(5):543-52
pubmed: 1127260
Curr Neurovasc Res. 2014;11(4):340-8
pubmed: 25219657
Infect Dis Clin North Am. 1999 Sep;13(3):735-50
pubmed: 10470564
Mediators Inflamm. 2013;2013:312476
pubmed: 23864766
J Infect Dis. 1989 Nov;160(5):891-5
pubmed: 2809260
Mediators Inflamm. 2004 Aug;13(4):269-73
pubmed: 15545058
Pediatr Int. 2006 Apr;48(2):118-24
pubmed: 16635168
Arq Neuropsiquiatr. 2005 Mar;63(1):7-13
pubmed: 15830057
Infect Dis Clin North Am. 2007 Sep;21(3):785-819, x
pubmed: 17826624
Biochemistry (Mosc). 2016 Nov;81(11):1293-1302
pubmed: 27914455
J Exp Med. 1990 Aug 1;172(2):497-507
pubmed: 2373990
Crit Care. 2014 Oct 20;18(5):567
pubmed: 25327849
Scand J Immunol. 2014 Jan;79(1):68-72
pubmed: 24313836
J Neuroimmunol. 2010 Apr 15;221(1-2):42-5
pubmed: 20202693
Pediatr Res. 2016 Oct;80(4):566-72
pubmed: 27486702
Clin Infect Dis. 2017 Mar 15;64(6):e34-e65
pubmed: 28203777
J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1381-5
pubmed: 19293173
Clin Rheumatol. 2014 Dec;33(12):1707-14
pubmed: 25085274
Pediatr Neurol. 2014 Jan;50(1):60-5
pubmed: 24138950

Auteurs

Semih K Olguner (SK)

Department of Neurosurgery, Adana City Training Research Hospital, Adana, Turkey. kivanc3olguner@hotmail.com.

Bulent Boyar (B)

Department of Neurosurgery, Cukurova University of Medical School, Adana, Turkey.

Derya Alabaz (D)

Pediatric Infectious Disease Department, Cukurova University of Medical School, Adana, Turkey.

Tahsin Erman (T)

Department of Neurosurgery, Cukurova University of Medical School, Adana, Turkey.

Kadir Oktay (K)

Department of Neurosurgery, Medical Park Hospital, Gaziantep, Turkey.

Ali Arslan (A)

Department of Neurosurgery, Adana City Training Research Hospital, Adana, Turkey.

Emre Bilgin (E)

Department of Neurosurgery, Adana City Training Research Hospital, Adana, Turkey.

Ali Ihsan Okten (AI)

Department of Neurosurgery, Adana City Training Research Hospital, Adana, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH